Second wave of the EU4Health calls published with 43,850 M€ of budget

Second wave of the EU4Health calls published with 43,850 M€ of budget

What is EU4Health Programme?

An “ambitious” response to the health crisis generated by COVID-19 – this is how the European Union defines the new EU4Health programme, approved last March, with a budget of 5.1 billion euros. It is the largest health programme ever in monetary terms, which will provide funding to EU countries, health organisations and NGOs.

The programme’s four main objectives are:

  1. To improve and foster health in the European Union.
  2. To tackle cross-border health threats
  3. To improve medicinal products, medical devices and crisis-relevant products.
  4. To strengthen health systems, their resilience and resource efficiency

What are the topics of the second wave of EU4Health programme?

On October, the second wave of calls for project grants under the 2021 Work Programme has been published. The topics range from health data, healthy lifestyles, infections, mental health, cancer, genomics and more. The available call budget is EUR 43 850 000.

These are the 13 calls published:

SINGLE-STAGE
Opening date: 14/10/2021
Deadline: 25/01/2022

OBJECTIVES

This consortium will design, develop, deploy and operate a network of nodes (representing different data brokers, holders and data consumers) federated by central services that may be provided by the European Commission.

This pilot will demonstrate and prove the value of an infrastructure and data ecosystem for the reuse of health data and assess the ability to scale towards a Union-wide infrastructure, as a core component of the European Health Data Space.

KEYWORDS
data, health, infraestructure, research, policy-making

SINGLE-STAGE
Opening date: 14/10/2021
Deadline: 25/01/2022
Status: Open

OBJECTIVES
The aim of the action is to increase awareness, knowledge sharing and capacity building in the area of mental health.

KEYWORDS
mental health, covid, impact, best practices

SINGLE-STAGE
Opening date: 14/10/2021
Deadline: 25/01/2022
Status: Open

OBJECTIVES
The aim of the action is to contribute to the implementation of Europe’s Beating Cancer Plan, which aims to support Member States’ efforts to extend the roll-out of routine HPV vaccination of girls and boys to eliminate cervical cancer and other cancers caused by HPV in the coming decade.

KEYWORDS
vaccination, cervical cancer, human papillomavirus

SINGLE-STAGE
Opening date: 14/10/2021
Deadline: 25/01/2022
Status: Open

OBJECTIVES
The ‘HealthyLifestyle4All’ is an initiative, which will build upon the Tartu Call for a Healthy Lifestyle. The aim of this initiative will be to promote healthy lifestyles in the Union, in particular amongst children, and its scope will be widened to involve various Commission services, civil society organisations and the Member States.

KEYWORDS
healthy, lifestyles, school, best practices

SINGLE-STAGE
Opening date: 14/10/2021
Deadline: 25/01/2022
Status: Open

OBJECTIVES
The action aims to reduce the risk of liver cancers associated with infections caused by the Hepatitis B and Hepatitis C viruses and the risk of gastric cancers caused by Helicobacter pylori.

KEYWORDS
liver, gastric, cancer, infections, helicobacter, pylori

SINGLE-STAGE
Opening date: 14/10/2021
Deadline: 25/01/2022
Status: Open

OBJECTIVES
The ‘EU Cancer Treatment Capacity and Capability Mapping’ action aims to map and share the different capabilities and expertise available across the Union.

KEYWORDS
cancer treatment, comprehensive cancer, centres

SINGLE-STAGE
Opening date: 14/10/2021
Deadline: 25/01/2022
Status: Open

OBJECTIVES
The aim of the action is to improve the quality of life and health status of cancer survivors, and to address their potential needs through the development and support for the wide use of new approaches to communication.
A ‘Cancer Survivor Smart Card’ will link with a ’resource’ function to give access to best practices, guidelines and recommendations specifically targeted to cancer survivors, with a view to helping them to address or to connect with professionals in different areas, to deal with the most common issues that survivors face, such as insufficient management of late and long-term effects of treatment, unmet psychosocial needs, self-management, pain management, and issues related to rehabilitation, emotional distress, tumour recurrence and metastatic disease.

KEYWORDS
cancer survivor, smart card, communication

SINGLE-STAGE
Opening date: 14/10/2021
Deadline: 25/01/2022
Status: Open

OBJECTIVES
The action aims at strengthening and supporting community-based service organisations in the Member States and neighbouring countries in the implementation of people-centre effective and integrated interventions, as well as linkage to care amongst groups at high risk of contracting HIV/AIDS, tuberculosis, viral hepatitis and sexually transmitted infections. It will also directly contribute to national programmes and public health measures, thus, supporting the implementation of internationally agreed goals.

KEYWORDS
community, services, human immunodeficiency, syndrome AIDS, tuberculosis, viral hepatitis

SINGLE-STAGE
Opening date: 14/10/2021
Deadline: 25/01/2022
Status: Open

OBJECTIVES
This action aims to support enhanced hospital and long-term care facilities infection prevention and control practices, as well as antimicrobial stewardship practices, and the development of best practices and implementation at all levels. It supports the commitment in the EU One Health Action Plan against AMR for the Commission to help to address patient safety in hospitals by supporting good practices in infection prevention and control and antimicrobial stewardship.

KEYWORDS
training activities, best practices, health, AMR, antimicrobial resistance

SINGLE-STAGE
Opening date: 14/10/2021
Deadline: 25/01/2022
Status: Open

OBJECTIVES
The new ‘Cancer Diagnostic and Treatment for All’ initiative, and the ‘Genomic for Public Health’ project will help Member States to improve access for individuals and cancer patients and survivors to prevention, diagnosis and treatment of cancer through personalised medicine, by upscaling available innovation in the field of innovative cancer diagnosis and treatment.

KEYWORDS
cancer, personalised treatment, diagnostic, genetic

SINGLE-STAGE
Opening date: 14/10/2021
Deadline: 25/01/2022
Status: Open

OBJECTIVES
The aim of the action is to identify potential viable effective anti-cancer drugs by making use and piloting ‘in-silico drug repurposing’ including by upscaling available innovation using advanced computing and the new big-data technologies and high-performance computing while reducing timeframes and development costs.

KEYWORDS
cancer, drugs, therapy

SINGLE-STAGE
Opening date: 14/10/2021
Deadline: 25/01/2022
Status: Open

OBJECTIVES
This action will aim to collect and organise in registries data on the safety, quality and efficacy of therapies applied in the field of medically assisted reproduction (MAR) and haematopoietic stem cell transplantation.

KEYWORDS
data, therapies, assisted reproduction, stem cells

SINGLE-STAGE
Opening date: 14/10/2021
Deadline: 25/01/2022

OBJECTIVES
The aim of this action is to improve access to and understanding of risk factors and health determinants to improve health outcomes for cancer.

KEYWORDS
cancer, prevention, health,